Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · Real-Time Price · USD

215.77

-5.12 (-2.32%)

At close: Aug 11, 2026, 4:00 PM EDT

216.00

+0.23 (0.11%)

Pre-market: Aug 12, 2026, 8:30 AM EDT

Axsome Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	319.85	322.93	315.35	386.19	200.84	86.47
Cash & Short-Term Investments	319.85	322.93	315.35	386.19	200.84	86.47
Cash Growth	5.56%	2.40%	-18.34%	92.29%	132.26%	-52.97%
Accounts Receivable	277.46	224.46	142	94.82	37.7	-
Inventory	37.88	27.94	15.73	15.14	4.32	-
Other Current Assets	21.38	13.65	11.98	8.12	2.78	0.05
Total Current Assets	656.57	588.99	485.06	504.26	245.64	86.52
Net Property, Plant & Equipment	20.03	21.42	5.97	7.62	1.14	0.94
Other Intangible Assets	37.36	40.52	46.89	53.29	59.66	-
Goodwill	12.04	12.04	12.04	12.04	10.31	-
Other Long-Term Assets	35.45	26.84	18.53	11.03	14.72	0.32
Total Assets	761.45	689.81	568.5	588.24	331.48	87.79
Accounts Payable	78.97	65.54	72	40.68	38.61	13.15
Accrued Expenses	299.63	232.85	147.99	90.5	51.63	9.3
Short-Term Debt	70	70	-	-	-	-
Current Portion of Leases	0.65	0.43	1.84	1.27	0.43	0.62
Other Current Liabilities	11.2	10.01	8.29	6.41	5.9	-
Total Current Liabilities	460.45	378.84	230.1	138.85	96.56	23.07
Long-Term Debt	117.96	117.75	180.71	178.07	94.26	49.09
Long-Term Leases	30.6	27.39	8.99	7.04	-	-
Other Long-Term Liabilities	69.14	77.54	91.68	73.3	31.1	-
Total Long-Term Liabilities	217.7	222.67	281.38	258.41	125.36	49.09
Total Liabilities	678.14	601.51	511.48	397.26	221.92	72.15
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-in Capital	1,505	1,394	1,180	1,027	705.89	424.83
Retained Earnings	-1,422	-1,306	-1,123	-835.57	-596.33	-409.2
Shareholders' Equity	83.3	88.3	57.02	190.98	109.56	15.63
Total Liabilities & Equity	761.45	689.81	568.5	588.24	331.48	87.79
Total Debt	219.21	215.57	191.53	186.37	94.68	49.71
Net Cash (Debt)	100.64	107.37	123.82	199.82	106.16	36.76
Net Cash Growth	14.73%	-13.29%	-38.04%	88.23%	188.77%	-72.51%
Net Cash Per Share	1.98	2.16	2.58	4.40	2.61	0.98
Book Value	83.3	88.3	57.02	190.98	109.56	15.63
Book Value Per Share	1.64	1.77	1.19	4.20	2.69	0.42
Tangible Book Value	33.9	35.73	-1.92	125.65	39.59	15.63
Tangible Book Value Per Share	0.67	0.72	-0.04	2.77	0.97	0.42

SEC Filings: 10-K · 10-Q